Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody - Wikidata - thesis-toulmin - TriplyDB

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

http://www.wikidata.org/entity/Q27489654

about

Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections An in-depth analysis of original antigenic sin in dengue virus infection Vaccinations for Neuroinfectious Disease: A Global Health Priority The Cellular Bases of Antibody Responses during Dengue Virus Infection Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope Antibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E Protein Role of microparticles in dengue virus infection and its impact on medical intervention strategies The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes Synergistic interactions between the NS3(hel) and E proteins contribute to the virulence of dengue virus type 1 Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity The structural basis for serotype-specific neutralization of dengue virus by a human antibody A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination The complexity of antibody-dependent enhancement of dengue virus infection Dengue virus antibodies enhance Zika virus infection Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus.Low copy numbers of DC-SIGN in cell membrane microdomains: implications for structure and function.Current progress in dengue vaccines Characterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cells.Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.Dissecting the human serum antibody response to secondary dengue virus infections Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka.Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera.In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III.Dengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection.Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.Utility, limitations, and future of non-human primates for dengue research and vaccine development Development of a humanized antibody with high therapeutic potential against dengue virus type 2

P2860

Q23925011-6C540C58-56A0-41B2-B576-4DC8C7F2700F Q24289014-D9B3EF3F-4017-4661-86BA-66CE9054C6A6 Q24606493-F2595E87-9797-40DE-B002-B605212E82BB Q26252588-96EEBCDB-6A7F-4454-A702-F0445A106624 Q26700056-7FF02408-CDD7-41E1-AC4A-FD19D631470D Q26700070-94C04995-6A2D-4DC4-85BD-D4F7446C9A37 Q26700120-890E850D-2DD1-42BF-BC62-65018CD37BE6 Q26700124-3ACF4DB2-ED21-4497-AC54-73F9A0195881 Q26860307-E87A0549-BE7D-40D0-9F6C-05D1BDB920B9 Q26995782-9B287449-44A2-497F-A90B-A36FCC56278D Q27304342-197B2C88-B62E-4017-98CA-49CF6A1D6805 Q27305534-2F45E2B6-AB2F-49E6-A8B2-7BF87753117F Q27469118-D9F9E33B-1EF1-44F6-806F-14549A0DE846 Q27491299-52380FCD-43E4-49C3-93A4-F75D5ABA87A8 Q27491317-4004BE4D-66BE-4155-9C3E-29ECF6C08804 Q27654848-58049289-353A-4255-ACFD-A753BA4D1151 Q27675965-DE41F44E-F363-4D3E-ABDD-FD340E3F594A Q27678419-AABDE0A6-1E72-41AB-B6E3-541D6BDD29BF Q27681306-CAF44306-5ABF-4609-A1D9-1CED20C22972 Q27681319-5DFA999C-94C9-4883-B8D3-84F49A4912C3 Q28114614-A18DC9BC-DA85-4C9F-830B-57A8B5FA41D7 Q28250383-E6CD2BFE-B6AF-47E7-A77F-75E4558E80AA Q28353949-73F2B44A-8206-45D2-AC99-35A303084EFA Q29994510-35FEB2A9-A84F-48D3-8239-DED1AAFB7EC2 Q30393251-6710EC04-7F5C-4E62-BC45-2912DCE01660 Q30584406-1F397EB9-67A8-41ED-A5E5-5B8DE92DE193 Q33408300-31A0C19C-7114-41D9-9C66-D6FE2EE5FFA3 Q33431345-46F0AE25-FFA4-4193-955E-54DD042F9193 Q33681310-69683401-4923-431F-941B-ED9B8DDF3BDE Q33728716-A270E33D-CAA1-4645-89C6-51B9D5EE3F8E Q33841059-AF5284D8-B9AE-418E-933D-0EDBB64A3CDB Q33845476-AAEC2A3E-5A3A-406C-BDA9-FD4A500606DE Q33945441-1CA5A68E-F19F-4111-AD23-2A2D54A0DE3B Q33968024-865C9B33-3746-4893-B24F-3796714C1FEA Q34042859-EAA01EA3-0EB2-4620-A85D-CA507C112225 Q34123956-E4C17B66-3136-4BEF-B4F2-B040FE3A0CD6 Q34184711-57A86003-F2D8-4A5A-83AA-00DFE937B277 Q34226542-2EE5290B-B16E-4674-A080-8824F34A7BDD Q34238916-803AB236-F547-449C-BECA-C4B033EBABDF Q34260219-C8755EF3-23B4-46AF-BC96-6E0EF0536916

P2860

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

http://www.wikidata.org/entity/Q27489654

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Dengue virus neutralization by ...... n domain III-reactive antibody

@ast

Dengue virus neutralization by ...... n domain III-reactive antibody

@en

Dengue virus neutralization by ...... n domain III-reactive antibody

@nl

type

label

Dengue virus neutralization by ...... n domain III-reactive antibody

@ast

Dengue virus neutralization by ...... n domain III-reactive antibody

@en

Dengue virus neutralization by ...... n domain III-reactive antibody

@nl

prefLabel

Dengue virus neutralization by ...... n domain III-reactive antibody

@ast

Dengue virus neutralization by ...... n domain III-reactive antibody

@en

Dengue virus neutralization by ...... n domain III-reactive antibody

@nl

P1433

Q27489654-900A8560-3D92-44D4-80A4-99C7F0946A66

P1476

Q27489654-1CD5D261-496E-48B9-88B7-B2B7CB7EED8A

P2093

Q27489654-52D79F7C-B111-4A3F-A37E-1FB22ACFB52F

Q27489654-5EE41723-36AB-4476-88F8-8B42C8183981

Q27489654-C39CF052-7A22-41B9-8C0D-6C51CA7A7908

Q27489654-F71490DE-A34B-4BD1-A4DD-6BD4411F5486

P2860

Q27489654-0976B523-0C6B-4187-80E4-5C651CFB8041

Q27489654-1082A13C-70BE-41E6-8CE7-802962CCBE62

Q27489654-1360B997-4FDA-49AD-995D-5C7ACE5EAC38

Q27489654-27A92FD1-5BEC-4FD6-9360-2922790C99F4

Q27489654-2BDC83F9-CD3B-4DF8-8354-D5777921D6E9

Q27489654-2F254089-1FEF-4AE3-A390-AA65EDC0AD86

Q27489654-2FBA0B6A-E3A7-443D-BD96-AAA9A3BBDD92

Q27489654-30AE7D58-B9C9-43FA-94BC-7070CE5D95C2

Q27489654-353C3DF2-E761-4CE5-8F42-46321D8E07E0

Q27489654-36AEFD1C-369E-47BF-AAB6-139F44939A7A

P304

Q27489654-12443C06-0C4A-4CF4-814E-5B5FB19CDFA8

P31

Q27489654-F8CBC21C-AC39-498D-A757-CB11FDB1C6BA

P3181

Q27489654-20EFD54E-9CF3-4C44-99ED-277FB05BEE48

P356

Q27489654-A79A912B-57EB-4A47-B2A2-05F5CF014854

P407

Q27489654-6A4ED052-B5AD-40CD-BFEA-E2C138607FBC

P433

Q27489654-732F5889-CAAF-424F-8FFC-FD47838FA7BD

P478

Q27489654-2A0B7A63-F15C-4362-A867-9F87862BA9E7

P50

Q27489654-5AE200F9-FD14-4319-B9DD-8CCC1125C403

P5008

Q27489654-7FA070F3-0C41-4D88-8BC9-987D6C76C5E9

P577

Q27489654-5C7590C4-EE4B-4761-A9DF-72254FA061CD

P5875

Q27489654-9EA83E21-66F7-4AC7-947B-CFD49673614E

P698

Q27489654-F4B76AFC-C5DE-4B21-AF8D-10D2E20517C8

P921

Q27489654-2C4EDA23-60F1-4BD5-B1A7-07E141D90390

Q27489654-B3A14604-DB8B-425E-AA9D-26EF8570CCB2

P932

Q27489654-3764386A-720E-4A6B-B7BB-03B29A31081C

P3181

P356

J.VIROL.2009.06.037

P1433

P1476

Dengue virus neutralization by ...... n domain III-reactive antibody

@en

P2093

Annette A Kraus

http://www.w3.org/2001/XMLSchema#string

Laura B Haymore

http://www.w3.org/2001/XMLSchema#string

Mary Ann Accavitti-Loper

http://www.w3.org/2001/XMLSchema#string

W M P B Wahala

http://www.w3.org/2001/XMLSchema#string

P2860

Dengue: defining protective versus pathologic immunity

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens

Crystal Structure of the West Nile Virus Envelope Glycoprotein

A ligand-binding pocket in the dengue virus envelope glycoprotein

Solution structure of the envelope protein domain III of dengue-4 virus

Single Antigen Detects both Immunoglobulin M (IgM) and IgG Antibodies Elicited by All Four Dengue Virus Serotypes

Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization

Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus

Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes

P304

103-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1024153

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.VIROL.2009.06.037

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

392

http://www.w3.org/2001/XMLSchema#string

P50

Aravinda de Silva

P5008

P577

2009-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26695084

http://www.w3.org/2001/XMLSchema#string

P698

19631955

http://www.w3.org/2001/XMLSchema#string

P921

P932

2746956

http://www.w3.org/2001/XMLSchema#string